Why Oracle (ORCL) Is Soaring After Securing Groundbreaking AI Cloud Deals With OpenAI and NVIDIA

• Oracle, in collaboration with OpenAI and NVIDIA, has secured landmark AI infrastructure deals, including a US$300 billion partnership with OpenAI and participation in building the U.S. Department of Energy's largest AI supercomputer, cementing its position in AI-driven cloud computing expansion.
• These developments have propelled Oracle's contract backlog to record levels and reinforced its critical role as a backbone provider for global AI workloads in both public and private sectors.
• We'll now explore how Oracle's transformative OpenAI partnership and growing AI contract backlog may influence its investment narrative and outlook.

Trump has pledged to "unleash" American oil and gas and these 22 US stocks have developments that are poised to benefit.

Oracle Investment Narrative Recap

To be an Oracle shareholder today is to believe that the company's swelling US$455 billion contract backlog, powered by landmark AI infrastructure deals and cloud momentum, will translate into sustained revenue growth as enterprise demand for AI workloads accelerates. While the latest news, such as AI-healthcare collaborations and fresh government partnerships, further reinforce Oracle’s critical role in AI-driven transformation, the most important short-term catalyst remains visible contract conversion into revenue, with the biggest immediate risk being heightened exposure to large AI customers and the potential for lumpy demand. For now, the impact of these announcements appears additive but not materially game-changing for these key drivers and risks.

Among the recent news, the partnership with OpenAI to deliver a multi-billion-dollar AI data center campus in Michigan stands out as directly relevant to Oracle’s core AI infrastructure thesis and backlog expansion story. This project, expected to break ground in 2026, highlights the scale at which Oracle is investing to support contract backlog conversion and future AI demand, while also illustrating the significant capital required to maintain leadership in this space.

But investors should also remain mindful that rising capital expenditures, if not matched by actual AI demand, could…

Read the full narrative on Oracle (it's free!)

Oracle's outlook anticipates $99.5 billion in revenue and $25.3 billion in earnings by 2028. This requires 20.1% annual revenue growth and a $12.9 billion earnings increase from today's $12.4 billion.

Uncover how Oracle's forecasts yield a $344.04 fair value, a 44% upside to its current price.

Exploring Other Perspectives

Private fair value estimates from the Simply Wall St Community range from US$170.68 to US$344.04, based on 25 investor analyses. Ongoing, the company’s reliance on a small number of massive AI contracts could amplify volatility if AI adoption patterns shift, so be sure to consider several viewpoints.

Explore 25 other fair value estimates on Oracle - why the stock might be worth 29% less than the current price!

Build Your Own Oracle Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Oracle research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Oracle research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Oracle's overall financial health at a glance.

Seeking Other Investments?

Our daily scans reveal stocks with breakout potential. Don't miss this chance:

• The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 24 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
• Rare earth metals are the new gold rush. Find out which 35 stocks are leading the charge.
• These 13 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com